Astellas Pharma on LinkedIn: 医薬品の枠を超えた...
Astellas introduces sustainable community initi...
Astellas gets FDA priority review for gastric c...
Pharmaceutical Technology
FDA Grants Full Approval for Astellas Pharma's ...
Astellas Pharma Joins Record Bond Sales by Japa...
Astellas Pharma US on LinkedIn: FDA Grants Prio...
Astellas Pharmaceuticals Establishes Open Innov...
Astellas Sues Over New Myrbetriq Patent to Reca...
FDA Approves Astellas’ Non-hormonal Menopause T...
Astellas Pharma: A Contrarian Investment (OTCMK...
Astellas licenses 4DMT’s AAV vector for ophthal...
Главная | Astellas Pharma Russia
Astellas
Home | Astellas Pharma Canada, Inc.
US FDA approves Astellas Pharma pill for menopa...
Astellas Trains Sights On Iveric Bio In $5.9 Bi...
Asia Business Daily on Twitter: "Astellas Pharm...
Japan's Astellas sees cancer drug fueling 29% p...
About | Astellas Pharma Ltd
Astellas, University of Tokyo extend partnershi...
FDA blocks Astellas’ Claudin cancer drug over m...
Astellas Pharma Inc. (4503N.MX) stock price, ne...
China Formally Arrests Japanese Employee of Dru...
Атлас лекарственных растений - YouTube
Astellas Offloads 5 Legacy Products to Germany’...
Astellas Pharma
Astellas' Prostate Cancer Drug Available In Jap...
Astellas Home page | Astellas Pharma Inc.
Astellas Pharma - Global Web Site on Behance
Astellas Pharma EMEA celebrates its 10th annive...
Astellas Pharma to acquire Propella Therapeutic...
Astellas Pharma Projects :: Photos, videos, log...